Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Draft legislation filed Sunday night, projected to save the government more than $900 billion, would cost millions of people ...

Oscar Health closed the first quarter with 2 million members, revenue of $3 billion and a net income of $275 million, but ...

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making plans for an initial public offering in 2025. | Omada Health, a virtual ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ... It's unclear how much the CVS formulary change will appeal to employers ...

House Republicans want to impose work requirements on some Medicaid recipients up to 64 years old and impose more costs on some beneficiaries to help pay for President Donald Trump’s planned sweeping ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.